My Pharmiweb.com (PharmiWeb)
INDIANAPOLIS, Sept 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ Eli Lilly and Company (NYSE: LLY) announced today it received approval from the U.S. Food and Drug Administration (FDA) for the use of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, in the first-line treatment of locally-advanced and metastatic non-small cell lung cancer (NSCLC), for patients with ...

FDA Classifies Medtronic's Notification Related To Improper Connection Of Sutureless Intrathecal Catheters As A Class ... (Medical News Today)
Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems as a Class I recall. The notification relates to the improper connection of its sutureless connector intrathecal catheters (referred to as SC catheters).